New nomenclature for fatty liver disease

Camilla Dalby Hansen; Katrine Prier Lindvig; Henning Grønbæk; Lise Lotte Gluud; Maja Thiele; Aleksander Krag

doi:10.61409/V12230778

New nomenclature for fatty liver disease

Translated title of the contribution: Not Available

Camilla Dalby Hansen, Katrine Prier Lindvig, Henning Grønbæk, Lise Lotte Gluud, Maja Thiele, Aleksander Krag

Abstract

This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.

Translated title of the contribution	Not Available
Original language	Danish
Article number	V12230778
Journal	Ugeskrift for Laeger
Volume	186
Issue number	19
ISSN	0041-5782
DOIs	https://doi.org/10.61409/V12230778
Publication status	Published - 6 May 2024

Access to Document

10.61409/V12230778

Cite this

@article{e2cc650ec56e48a9b475d526d211d360,

title = "New nomenclature for fatty liver disease",

abstract = "This review investigates that, in 2023, fatty liver disease underwent a name change to {"}steatotic liver disease{"} (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.",

keywords = "Humans, Terminology as Topic, Risk Factors, Fatty Liver/classification, Fatty Liver, Alcoholic/classification, Alcohol Drinking/adverse effects, Non-alcoholic Fatty Liver Disease/classification, Liver Diseases, Alcoholic/classification",

author = "Hansen, {Camilla Dalby} and Lindvig, {Katrine Prier} and Henning Gr{\o}nb{\ae}k and Gluud, {Lise Lotte} and Maja Thiele and Aleksander Krag",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = may,

day = "6",

doi = "10.61409/V12230778",

language = "Dansk",

volume = "186",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "19",

}

TY - JOUR

T1 - New nomenclature for fatty liver disease

AU - Hansen, Camilla Dalby

AU - Lindvig, Katrine Prier

AU - Grønbæk, Henning

AU - Gluud, Lise Lotte

AU - Thiele, Maja

AU - Krag, Aleksander

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/5/6

Y1 - 2024/5/6

N2 - This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.

AB - This review investigates that, in 2023, fatty liver disease underwent a name change to "steatotic liver disease" (SLD). SLD now includes metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic and alcohol-related liver disease (MetALD). The renaming aims to better incorporate alcohol intake and metabolic risk factors into disease classification and to diminish the stigma associated with the previous nomenclature. Early identification of the patient's aetiology is important for the prognosis which can be improved by interventions against the causative risk factors.

KW - Humans

KW - Terminology as Topic

KW - Risk Factors

KW - Fatty Liver/classification

KW - Fatty Liver, Alcoholic/classification

KW - Alcohol Drinking/adverse effects

KW - Non-alcoholic Fatty Liver Disease/classification

KW - Liver Diseases, Alcoholic/classification

UR - http://www.scopus.com/inward/record.url?scp=85194850570&partnerID=8YFLogxK

U2 - 10.61409/V12230778

DO - 10.61409/V12230778

M3 - Review

C2 - 38808766

SN - 0041-5782

VL - 186

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 19

M1 - V12230778

ER -

New nomenclature for fatty liver disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this